-
-
-
-
-
-
-
Keenova presents plantar fibromatosis clinical data at ACFAS meeting
-
-
-
-
-
-
-
Mallinckrodt completes Par Health spin-off, rebrands as Keenova Therapeutics
-
-
-
-
-
-
-
Mallinckrodt (MNK) and Endo (NDOI) Announce Planned Leadership Team for Merged Company
-
-
-
-
-
-
-
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
-
-
-
-
-
-
-
Mallinckrodt (MNK) to Sell Therakos Business to CVC for $925M
-
-
-
-
-
-
-
Mallinckrodt (MNK) Files Chapter 11 Bankruptcy
-
-
-
-
-
-
-
Mallinckrodt to Report Earnings Results for First Quarter 2023
-
1,219,402 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

